Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement

(NASDAQ:ARWR) PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced a global licensing and collaboration agreement with Novartis for ARO-SNCA, ...

How might this partnership shift Arrowhead’s competitive position in the RNAi space and influence market sentiment? What development milestones and royalty structures are included in the Novartis deal, and how could they impact future earnings? How will the $200 million upfront payment affect Arrowhead’s cash runway and valuation?
Symbol: ARWR
Partnership
13 days ago
Read more businesswire

XCharge Launches GridLink Across Europe, Powered by Proprietary Battery Technology for Enhanced Safety

(NASDAQ:XCH) HAMBURG, Germany--(BUSINESS WIRE)--XCharge North America (“XCharge NA”) and XCharge Europe (“XCharge EU”), subsidiaries of high-power EV charging and battery-integrated solution provid...

What are the regulatory and adoption risks for XCharge's proprietary battery technology in the EU market? What is the competitive positioning of GridLink against other EV charging solutions in Europe, and how might it influence market share? How will the GridLink launch affect XCH's revenue forecasts and earnings guidance?
Symbol: XCH
Product launch
13 days ago
Read more businesswire

Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak

(NASDAQ:THTX) MONTREAL, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is...

What strategic synergies and operational advantages does the partnership with Future Pak provide, and how might it affect Theratechnologies' drug development timeline and commercial outlook? How likely is it that the proxy advisor recommendations will translate into sufficient shareholder support to pass the Arrangement Resolution? What are the specific terms and valuation of the arrangement with Future Pak, and how will it impact Theratechnologies' balance sheet and cash flow?
Symbol: THTX
Mergers
13 days ago
Read more globenewswire

Enthusiast Gaming Completes Direct Sales Business Divestment

(EGLX) Enthusiast Gaming Completes Direct Sales Business Divestment

What is the intended use of the divestiture proceeds (e.g., debt reduction, acquisitions, reinvestment) and how might that impact the stock valuation? How will the divestment reshape the company's growth strategy and competitive positioning within the gaming sector? What are the financial ramifications of the direct sales business divestiture on Enthusiast Gaming's upcoming earnings?
Symbol: EGLX
Mergers
13 days ago
Read more globenewswire

Codere Online Announces Chief Financial Officer Transition to New Role

(NASDAQ:CDRO) Luxembourg, Grand Duchy of Luxembourg, September 2, 2025 – (GLOBE NEWSWIRE) Codere Online (Nasdaq: CDRO / CDROW, the “Company”), a leading online gaming operator in Spain and Latin Am...

Could this leadership change trigger any strategic or operational adjustments that might impact the company's valuation or market position? Who is the identified successor or interim CFO, and what relevant experience do they have in the online gaming industry? What effect will the CFO's departure have on Codere Online's upcoming financial guidance and earnings forecasts?
Symbol: CDRO
Management
13 days ago
Read more globenewswire

BridgeBio to Present Phase 2 Proof-of-Concept Data for Encaleret in Post-Surgical Hypoparathyroidism

(NASDAQ:BBIO) PALO ALTO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on geneti...

How does BridgeBio's development timeline and data expectations compare with competitors developing therapies for hypoparathyroidism or related skeletal dysplasias? What is the total addressable market and commercial upside for an oral therapy in post‑surgical hypoparathyroidism versus existing treatments? How will the upcoming Phase 2 proof‑of‑concept data for Encaleret affect BBIO's short‑term stock volatility?
Symbol: BBIO
Clinical trials
13 days ago
Read more globenewswire

Nexxen Announces August 2025 Share Repurchase Program Summary

(NASDAQ:NEXN) NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep exper...

How does Nexxen's buyback activity compare to its peers in the advertising technology sector and what could that indicate about competitive positioning? What is the remaining cash reserve after the repurchase and does the company have sufficient funds for future buybacks or dividends? How will the August 2025 share repurchase affect Nexxen's earnings per share and valuation metrics?
Symbol: NEXN
Buybacks
13 days ago
Read more globenewswire

Phillips Edison & Company Declares Quarterly Dividends; Increases Monthly Dividend Distribution by 5.7%

(NASDAQ:PECO) CINCINNATI, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-qua...

What short‑term price reaction and volatility can traders expect following the announcement? Is the increased dividend sustainable given PECO's current cash flow generation and debt profile? How will the 5.7% dividend increase affect PECO's dividend yield and valuation multiples relative to its peers?
Symbol: PECO
Dividends
13 days ago
Read more globenewswire